Found: 7
Select item for more details and to access through your institution.
Amyloid‐Related Imaging Abnormalities in the DIAN‐TU‐001 Trial of Gantenerumab and Solanezumab: Lessons from a Trial in Dominantly Inherited Alzheimer Disease.
- Published in:
- Annals of Neurology, 2022, v. 92, n. 5, p. 729, doi. 10.1002/ana.26511
- By:
- Publication type:
- Article
Validation of 3‐ and 5‐point severity scales to assess ARIA‐E.
- Published in:
- Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring, 2023, v. 15, n. 4, p. 1, doi. 10.1002/dad2.12503
- By:
- Publication type:
- Article
Comparing ARIA‐E severity scales and effects of treatment management thresholds.
- Published in:
- Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring, 2022, v. 14, n. 1, p. 1, doi. 10.1002/dad2.12376
- By:
- Publication type:
- Article
Historical Buildings Potential to Power Urban Electromobility: State-of-the-Art and Future Challenges for Nearly Zero Energy Buildings (nZEB) Microgrids.
- Published in:
- Energies (19961073), 2022, v. 15, n. 17, p. 6296, doi. 10.3390/en15176296
- By:
- Publication type:
- Article
Baseline risk factors for developing ARIA‐E from the SCarlet RoAD and Marguerite RoAD open‐label extension studies.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2022, v. 18, n. 10, p. 1, doi. 10.1002/alz.065856
- By:
- Publication type:
- Article
Comparing ARIA‐E severity scales and effects of treatment management thresholds.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2022, v. 18, n. 5, p. 1, doi. 10.1002/alz.063848
- By:
- Publication type:
- Article
Characterization of amyloid‐related imaging abnormality in the DIAN‐TU‐001 trial.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2021, v. 17, p. 1, doi. 10.1002/alz.056393
- By:
- Publication type:
- Article